LeMaitre Vascular, a company specializing in vascular devices and implants, announced it will participate in two key investor conferences in June: the Jefferies Global Healthcare Conference on June 3 in New York City and the Goldman Sachs Annual Global Healthcare Conference on June 10 in Miami Beach. Management will engage in a fireside chat and a presentation, respectively, providing updates and insights into the company’s progress and strategy. These events offer LeMaitre an opportunity to connect with investors and highlight its role in treating peripheral vascular disease, which affects over 200 million people globally.
Navios Maritime (NMM) is rated Buy due to its strong earnings, organic growth, and a significant 56% discount to net asset value (NAV). The company operates a diversified fleet of 149 vessels across dry bulk, containerships, and tankers, maintaining ...
Levi & Korsinsky has started an investigation into Regeneron Pharmaceuticals for potentially misleading investors about the results of a clinical trial. In March 2026, Regeneron's investor relations VP expressed hope for positive trial outcomes of a ...
Levi & Korsinsky has started an investigation into Prestige Consumer Healthcare following the company's failure to meet its Q4 and full-year financial projections, including adjusted gross margin, free cash flow, and adjusted EPS. Additionally, Prest...
Levi & Korsinsky has started an investigation into TriSalus Life Sciences following the company's Q1 2026 revenue of $8.9 million, which missed Wall Street's $9.4 million estimate. The company also lowered its full-year 2026 revenue forecast to $54 m...
Bitcoin whale traders have shifted aggressively toward short positions, reflecting growing defensive sentiment amid weakening broader crypto momentum. Large speculative wallets reduced altcoin exposure and increased leveraged Bitcoin shorts, with one...
